These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 21612661

  • 1. Alternative statistical methods for estimating efficacy of interferon beta-1b for multiple sclerosis clinical trials.
    Mieno MN, Yamaguchi T, Ohashi Y.
    BMC Med Res Methodol; 2011 May 26; 11():80. PubMed ID: 21612661
    [Abstract] [Full Text] [Related]

  • 2. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.
    Nikfar S, Rahimi R, Abdollahi M.
    Clin Ther; 2010 Oct 26; 32(11):1871-88. PubMed ID: 21095482
    [Abstract] [Full Text] [Related]

  • 3. [Current status of interferon beta-1b in multiple sclerosis therapy].
    Hartung HP.
    Med Klin (Munich); 2001 Sep 15; 96 Suppl 1():11-6. PubMed ID: 11603110
    [Abstract] [Full Text] [Related]

  • 4. Interferon-β-1b: a review of its use in multiple sclerosis.
    Plosker GL.
    CNS Drugs; 2011 Jan 15; 25(1):67-88. PubMed ID: 21128695
    [Abstract] [Full Text] [Related]

  • 5. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.
    Kappos L, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Radü EW, Metzig C, Bauer L, Lanius V, Sandbrink R, Pohl C, BENEFIT Study Group.
    Lancet Neurol; 2009 Nov 15; 8(11):987-97. PubMed ID: 19748319
    [Abstract] [Full Text] [Related]

  • 6. The role of interferons in the treatment of multiple sclerosis.
    Kelley CL.
    J Neurosci Nurs; 1996 Apr 15; 28(2):114-20. PubMed ID: 8718760
    [Abstract] [Full Text] [Related]

  • 7. [Report from the Satellite Symposium: Leading the way: outstanding efficacy of interferon beta-1b right from the start. Berlin, Germany, 06.24.2002].
    Cendrowski W.
    Neurol Neurochir Pol; 2002 Apr 15; 36(6):1260-3. PubMed ID: 12715704
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases?
    Verdun E, Isoardo G, Oggero A, Ferrero B, Ghezzi A, Montanari E, Zaffaroni M, Durelli L, Betaferon Safety Trial (BEST) Study Group.
    J Interferon Cytokine Res; 2002 Feb 15; 22(2):245-55. PubMed ID: 11911808
    [Abstract] [Full Text] [Related]

  • 12. Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis.
    Penner IK, Stemper B, Calabrese P, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Pleimes D, Lanius V, Pohl C, Kappos L, Sandbrink R.
    Mult Scler; 2012 Oct 15; 18(10):1466-71. PubMed ID: 22492127
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Annualized relapse rate of first-line treatments for multiple sclerosis: a meta-analysis, including indirect comparisons versus fingolimod.
    Roskell NS, Zimovetz EA, Rycroft CE, Eckert BJ, Tyas DA.
    Curr Med Res Opin; 2012 May 15; 28(5):767-80. PubMed ID: 22462530
    [Abstract] [Full Text] [Related]

  • 15. Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis.
    Arnason BG.
    J Neurol; 2005 Sep 15; 252 Suppl 3():iii28-iii33. PubMed ID: 16170497
    [Abstract] [Full Text] [Related]

  • 16. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis.
    Schwid SR, Panitch HS.
    Clin Ther; 2007 Sep 15; 29(9):2031-48. PubMed ID: 18035202
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.